tiprankstipranks
Advertisement
Advertisement
Vivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright
PremiumThe FlyVivos Therapeutics price target lowered to $2.50 from $7 at H.C. Wainwright
2M ago
Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global
Premium
The Fly
Vivos Therapeutics price target lowered to $1.75 from $2.50 at Alliance Global
2M ago
Vivos Therapeutics Balances Growth Hopes With Cash Strain
Premium
Company Announcements
Vivos Therapeutics Balances Growth Hopes With Cash Strain
2M ago
Vivos Therapeutics files to sell 3.96M shares of common stock for holders
PremiumThe FlyVivos Therapeutics files to sell 3.96M shares of common stock for holders
3M ago
Vivos Therapeutics Appoints Gregg Johnson to Board
Premium
Company Announcements
Vivos Therapeutics Appoints Gregg Johnson to Board
4M ago
Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology
Premium
The Fly
Vivos, SoundHealth collaborate to expand access to SoundHealth’s technology
4M ago
Vivos Therapeutics opens sleep center in Auburn Hills, Michigan
PremiumThe FlyVivos Therapeutics opens sleep center in Auburn Hills, Michigan
6M ago
Vivos Therapeutics Secures $2M Note with Avondale
Premium
Company Announcements
Vivos Therapeutics Secures $2M Note with Avondale
6M ago
Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges
Premium
Company Announcements
Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100